JOHN NEIS - 14 Feb 2025 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Director
Signature
/s/ Christina Blakley, attorney-in-fact for John Neis
Issuer symbol
CLRB
Transactions as of
14 Feb 2025
Net transactions value
$0
Form type
4
Filing time
18 Feb 2025, 16:06:31 UTC
Previous filing
18 Jun 2024
Next filing
16 Dec 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +60,000 $0.000000 60,000 14 Feb 2025 Common Stock 60,000 $0.2900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full on February 14, 2026, subject to the reporting person's continued service through the applicable vesting date.